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INTRODUCTION
Post-operative sore throat (POST) is a common
phenomenon after general anaesthesia with
endotracheal intubation. It is considered as the second
leading minor adverse event after post-operative nausea
and vomiting.1 The incidence vary widely but reportedly
as high as 49 and 69.6% in two separate studies in our
sub-region.2,3 Notable risk factors for developing
POST include female sex, airway instrumentation and
airway surgeries.4 Mucosal injury during airway
instrumentation is a recognizable pathophysiological
mechanism in the literature. Endotracheal anaesthesia
incorporate many manoeuvres that can cause these
injuries including laryngoscopy, suctioning, endotracheal
intubation and sometimes oro-/nasogastric tube
passage.
Gentle airway manipulation at anaesthetic induction
can minimize mucosal injury and prevent occurrence
of  POST. Pre-induction administration of  topical/
local anti-nociceptive and anti-inflammatory agents
attenuate POST by counteracting the inflammation or
nociception induced by mucosal injury.5–7
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The peripheral nerves in the airway subserving
nociception contain N-methyl D-Aspartate receptors
(NMDAR).8 Antagonists to NMDAR are considered
anti-nociceptive and have been investigated for POST
in the forms of  gargle, lozenge and nebulization with
varied outcomes.9–11 Nebulization however offers the
unique advantage of even distribution over all areas
exposed to instrumentation and mucosal damage while
the gargle and lozenge forms are restricted to the
supraglottic region with considerable inter-patient
variability during administration.
Magnesium and Ketamine are commonly available
NMDAR antagonists with anti-inf lammatory
properties. Previous studies compared these agents with
placebo using varied doses and application patterns.
We decided to undertake this study to test and compare
the efficacies of pre-induction nebulized Magnesium
and Ketamine for POST attenuation within 24 hours
following general anaesthesia with endotracheal
intubation.
ABSTRACT
Background: Sore throat is a common post-operative complaint which can cause
significant distress and morbidity. We tested and compared the efficacy of  nebulized
Magnesium and Ketamine on the incidence and severity of sore throat within the
first 24 hours after general anaesthesia.
Objective: To compare the incidence and severity of  post-operative sore throat at 2,
4, 8, 12 and 24 hours after extubation following pre-induction administration of
nebulized Magnesium and Ketamine.
Method: In this randomized controlled trial, 99 adult ASA I and II patients between
the ages of 16 – 65 years were administered nebulized Ketamine 50 mg, Magnesium
Sulphate 250 mg or saline for ten minutes prior to induction of general anaesthesia
and orotracheal intubation. Incidence and severity of post-operative sore throat
were assessed at 2, 4, 8, 12 and 24 hours post extubation.
Result: The incidence of sore throat at 4, 8, 12 and 24 hours post tracheal extubation
were significantly lower in the Magnesium (18.2%, 12.1%, 0, 0; p = 0.009, 0.006,
<0.0001, 0.003) and Ketamine group (24.2%, 12.1%, 6.1%, 0; p = 0.041, 0.006, 0.001,
0.003) compared with the saline group (48.5%, 42.4%, 39.4%, 24.2%). Patients also
had significantly less severe sore throat at 4 and 8 hours post extubation in both
Magnesium and Ketamine groups (p = 0.0 11, 0.041).
Conclusion: Pre-induction nebulization of Ketamine or Magnesium can decrease
the incidence and severity of sore throat in the first 24 hours after anaesthesia.
Keywords: Nebulize, Sore throat, Magnesium, Ketamine.
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METHOD
We conducted a double blind randomized controlled
trial at the University College Hospital, Ibadan over a
6 month period. Ninety-nine eligible ASA I and II
patients scheduled for elective surgical procedures in
supine position under general anaesthesia were
recruited. Patients with recent sore throat, chronic
airway disease, anticipated difficult airway or
undergoing head and neck procedures were excluded.
Our sample size was calculated from the presumption
that the incidence of POST in our environment is
69.6%.3 To show a 50% reduction in incidence using a
power of  80% with a 95% confidence interval, power
analysis generated 30 patients per group.12 We added
10% of the calculated sample size to account for
attrition. Following institutional ethics approval, a block
randomisation using computer generated table of
random numbers divided the prospective patients into
equal groups of  33. Written informed consent was
obtained from each patient at the preoperative review.
Patients were allocated according to group to receive
one of three nebulized medications: Magnesium
sulphate 250mg (Group M); Ketamine 50mg (Group
K) and saline. The medications were made up to 5ml
volume with sterile water and delivered with a
compressor nebulizer (Omron Healthcare Co. Ltd.,
Japan) for 10 minutes. The drugs were indistinguishable
in colour and to ensure blinding, an assistant carried
out the nebulization. During nebulization, patients were
inclined at 450 and encouraged to simultaneously
breathe through the mouth and nose.
Induction was done with Propofol 2mg/kg and
Fentanyl 2mcg/kg. Laryngoscopy was performed by
a single anaesthetist after neuromuscular block with
Pancuronium 0.1mg/kg was confirmed with ulnar
nerve stimulation (MS-IVA, Life-Tech Inc, USA). Male
subjects were intubated with lubricated size 7.5mm
ID while females had 7.0mm ID high volume low
pressure cuffs (Smiths Medical Int. Ltd, UK). The cuff
pressures were monitored and kept at 25 cmH2O with
a manual manometer (NS60-TRS-CP, Tri-anim Health
Services, Ireland). Anaesthesia was maintained with
Isoflurane 1 – 2% in oxygen and morphine titrated to
effect. Patients were monitored throughout surgery as
per protocol.
At the end of  surgery, Paracetamol 0.6g was
administered while residual neuromuscular block was
reversed with Neostigmine 2.5mg and Atropine 1.2mg.
Gentle blind oropharyngeal suctioning was done prior
to awake extubation. Patients were interviewed for
POST at 2, 4, 8, 12 and 24 hours after tracheal
extubation. Severity of POST was graded according
to NRS 0 – 10. Strepsil® lozenges was prescribed for
those with severe POST.
Our primary outcome was the incidence of POST at
4 hours post extubation while secondary outcomes
were incidences and severities observed at 2, 8, 12
and 24 hours as well as correlation between POST
and gender, external laryngeal manipulation and
laryngoscopy grade. Statistical analysis were performed
with IBM SPSS 21 (Chicago, IL., USA). Tests of
association for continuous variables were done with
independent t-test and one-way analysis of variance
(ANOVA) while categorical variables were analysed
with chi square test. Fisher exact was used for cell count
<5. Level of significance was set at P <0.05.
RESULT
We recruited 107 patients between July and December
2016: two patients declined consent, one patient had
intraoperative surgical complications that necessitated
post-operative ICU care while five patients dropped
out for multiple attempts at laryngoscopy. Ninety-nine
patients completed the study comprising 47 males and
52 females. The mean age and weight were 43.8 years





41.2 ± 13.3 45.5 ± 12.1 44.6 ± 13.3 0.366
Weight in kg
(means ± SD)












Table 1: Demographic characteristics of  patients
SD: Standard Deviation
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and 68.9 kg respectively. Age, sex and weight were
not significantly different among the three groups.
Table 1 shows the demographic characteristics. The
characteristics of the three groups as it relates to surgery
and anaesthesia (including laryngoscope blade size,
laryngoscopy grade, use of external laryngeal
manipulation, durations of intubation, surgery and
anaesthesia) are also comparable (Table 2).
POST at 4, 8, 12 and 24 hours between Magnesium
and saline (p = 0.009, 0.006, d”0.001, 0.003) and
Ketamine and saline (p = 0.041, 0.001, 0.003) as shown
in Table 3. No significant difference was found when
Ketamine was compared with Magnesium at all
observation times (Table 4). Significantly more patients
suffered severe POST at 4 and 8 hours in group S
compared with group M and K (Table 5). No
Variable Saline Ketamine Magnesium
f-test
(P value)
Duration of intubation (sec)
(mean ± SD)
17.3 ± 4.4 17.0 ± 5.2 16.1 ± 4.6 0.529
Duration of surgery (min)
(mean ± SD)
118.7 ± 44.9 118.6 ± 42.3 126.6 ± 36.9 0.668
Duration of anaesthesia (min)
(mean ± SD)
153.0 ± 43.3 156.2 ± 43.6 164.1 ± 37.6 0.537
χ2
(p-value)









Frequency of ELM {n (%)} 13 (46.4) 8 (28.6) 7 (25.0) 0.214










ELM: External Laryngeal Manipulation
Sec: Second
Min: Minute
Table 2: Comparison of  factors related to anaesthesia and surgery (N = 33 in each group).
The overall incidence of POST at 4 hours was 30.3%.
The incidence was highest in group S (48.5) and lowest
in group M (18.2%) compared with group K (24.2%).









2 10 (30.3) 8 (24.2) 0.580 2 (6.1) 0.011⃰
4 16 (48.5) 8 (24.2) 0.041⃰ 6 (18.2) 0.009⃰
8 14 (42.4) 4 (12.1) 0.006⃰ 4 (12.1) 0.006⃰
12 13 (39.4) 2 (6.1) 0.001⃰ 0 (0.0) ≤0.0001⃰
24 8 (24.2) 0 (0.0) 0.003⃰ 0 (0.0) 0.003⃰






2 8 (24.2) 2 (6.1) 4.243 0 .082
4 8 (24.2) 6 (18.2) 0.363 0 .764
8 4 (12.1) 4 (12.1) 0.000 1.000
12 2 (6.1) 0 (0.0) 2.063 0.492
24 0 (0.0) 0 (0.0) NA NA
n: Number of patients with POST per group
Table 4: Comparison of  incidence of  POST [Ketamine vs Magnesium (N = 33 in each group)
n: Number of patients with POST per group
NA: Not Available
correlation was found between POST at 4 hours and
gender, external laryngeal manipulation at intubation
and laryngoscopic grade in the three groups (Table 6).
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DISCUSSION
The major finding of this study is that prophylactic
administration of nebulized Magnesium or Ketamine
can decrease incidence and severity of POST within
the first 24 hours following endotracheal anaesthesia.
The suggested mechanism for the attenuation is the
anti-nociceptive and anti-inflammatory properties of
NMDAR antagonists.8 Typically, POST occurs
following noxious stimulation provoked by
inflammation that results from mucosal injuries.4,10
Excitatory amino acids such as glutamate and
inflammatory mediators are released after such
mucosal injuries or following stretch of pharyngeal
muscles by instrumentation.13 Prior occupation of
NMDAR by Ketamine or Magnesium molecules
prevents glutamate mediated central sensitization and
sensation of  POST.8
In our study, Magnesium significantly attenuated POST
at 2 hours post extubation when compared with saline.
Teymourian et al 14 also demonstrated significant
attenuation of POST at 2 hours following Magnesium
gargles. On the contrary, we did not find a significant
attenuation of POST at 2 hours post extubation when
Ketamine was compared with saline. This may likely
be due to manifestations of new mucosal injuries at
emergence in the Ketamine group since we recorded
twice as many blood stained suction tubes at emergence
in the Ketamine group when compared with
Magnesium.
The highest incidence of  POST observed across the
groups at 4 hours correlates with the incidence found
in similar studies.15,16 It may be indicative of  the peak










2 Mild 6 (60.0) 6 (75.0) 1 (50.0) 0.719
Moderate 4 (40.0) 2 (25.0) 1 (50.0)
4 Mild 2 (12.5) 4 (50.0) 4 (66.7) 0.011⃰
Moderate 5 (31.3) 4 (50.0) 2 (33.3)
Severe 9 (56.2) 0 (0.0) 0 (0.0)
8 Mild 3 (21.4) 2 (50.0) 4 (100) 0.041⃰
Moderate 5 (35.7) 2 (50.0) 0 (0.0)
Severe 6 (42.9) 0 (0.0) 0 (0.0)
12 Mild 5 (38.5) 2 (100) 0 (0.0) 0.104
Moderate 8 (61.5) 0 (0.0) 0 (0.0)
24 Mild 4 (50.0) 0 (0.0) 0 (0.0) N/A
Moderate 4 (50.0) 0 (0.0) 0 (0.0)
Table 5: Comparison of  severity of  POST (N = 33 in each group).
n: Number of patients with POST per group.
NA: Not Available.
Patients with POST (n)/Sub-group (n1)
Variable Saline Ketamine Magnesium Total p-value
Sex
Male 5/14 3/13 3/20 11/47 0.115
Female 11/19 5/20 3/13 19/52
ELM
Yes 9/13 1/8 1/7 11/28 0.164
No 7/20 7/25 5/26 19/71
LG
1 7/20 3/19 4/23 14/62 0.089
2 6/10 5/13 2/8 13/31
3 3/3 0/1 0/2 3/6
Table 6: Analysis of  risk factors for POST at 4 hours (N = 33 in each group).
n: Number of patients with POST per sub group
n1: Number of patients with each variable per group
ELM: External Laryngeal manipulation
LG: Laryngoscopy grade (Cormack and Lehane)
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mediators. This is also the period where the severest
of  POST was observed across the groups although
no patient in the test groups had severe POST at any
time during our study. We observed an increase in
incidence in the Magnesium group between 2 and 4
hours. This could be due to a more gradual developing
inflammation not evident at earlier post-operative
period. We utilized the numerical rating scale for
assessment of severity of POST because of its
simplicity which makes it easily understood by our
patient population. This also makes it easy to use in
the early post-operative period where the residual
effect of anaesthesia may still be present.
The decrease in incidence and severity from the 8th to
the 24th hour period in all the groups may reflect
resolution of inflammation and decreased nociception.
This assumption is reinforced by decrease in severe
POST in the non-tested (control) group by 12 hours
and beyond. At 24 hours, the absence of any case of
POST in both test groups coupled with an incidence
of  24.2% in the control group suggest that the effect
of  the NMDAR antagonists extend to this period.
Since the supposed mechanism is local anti-
inflammatory and anti-nociceptive actions, continuous
absorption from the mucous surface should diminish
their effect over time. The rate of absorption may
also account for the difference in incidence between
the two NMDAR antagonists at different times. Many
randomized controlled studies on NMDAR
antagonism and POST report decreasing incidence
over a 24 hour period.9,15,16 In contrast, observational
studies conducted after 24 hours of anaesthesia report
high incidences of  POST.1,2,17
We optimised the nebulization process to ensure
maximum delivery of the active agent. Previous studies
did not address the nebulization process which can
significantly affect the amount of drug molecules
delivered to the active sites. The recommended fill
volume for nebulization is 4 – 5 ml.18 The volume we
administered was made up to 5 ml for this reason.
The nebulization was carried out for 10 minutes
because the nebulizer utilized for this study delivers
0.5 ml/min and would require 10 minutes to
completely nebulize a 5 ml solution. Compressor
nebulizer was our preferred form of  nebulization
because of the advantages of convenience, ease of
operation, short inhalation times, efficient lung
deposition and cost. We also encouraged subjects to
simultaneously breathe through the mouth and nose
to maximise delivery and reduce filtration of droplets
that would otherwise occur with nasal breathing alone.
This study demonstrated an insignificant higher
incidence in females; previous studies had shown a
greater predisposition to POST by females.19–21 This
outcome is possibly due to our sample size as well as
the unequal representation of the sexes in the study
groups. The female sex is adjudged to be more
predisposed to POST because of the relative small
larynx in relation to the ETT size applied.22 We chose
ETT sizes of 7.0 and 7.5 mm ID for women and
men respectively because it was shown in a previous
study that incidences of POST in women intubated
with these sizes were not significantly different.3
All recruited patients were subjected to a single
laryngoscopy attempt. Laryngeal exposure and
visualisation were aided by external laryngeal
manipulation (ELM) in some patients. Application of
ELM may suggest initial poor laryngeal view and not
necessarily a difficult laryngoscopy/intubation. The
factors that can affect laryngeal view at laryngoscopy
include operator technique, inadequate muscle
relaxation, improper positioning and patient unique
anatomical features. Operator guided ELM is known
to be superior to both basic laryngoscopy and
assistant’s ELM in Cormack and Lehane score and
percentage of  glottic opening.23 We found a greater
predisposition in patients who had ELM with an
absolute risk reduction of 12%. It is likely that the
mucosa of the anterior larynx becomes more
vulnerable to injury by the curved tip of  the ETT when
displaced.
The grade of laryngeal views obtained in this study
were largely a function of patients’ unique anatomical
attribute since a single anaesthetist performed all
laryngoscopies. All of  the six patients who had
Cormack and Lehane grade 3 view at laryngoscopy
were assisted by ELM and had durations of intubation
more than 15 seconds. The incidence of  POST at 4
hours in this group indicates that not all difficult
laryngoscopy eventually result in POST. No conclusion
can however be drawn from this finding owing to the
small number involved. The interaction between ELM,
laryngoscopy grade and POST is also not clearly
defined.
The evidence required to recommend NMDAR
antagonists as effective prophylaxis against POST can
only be substantiated by larger trials or meta-analysis.
Although, our study showed an absolute risk reduction
of 25% and 31% at 4 hours for Ketamine and
Magnesium respectively, the calculated number needed
to treat were 4 and 3 respectively. These can be
considered high for a common minor post-operative
anaesthetic complication.
LIMITATIONS
We had some limitations during the study. Post-
operative analgesia could not be standardised in timing
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and dosage during the period of  observation hence
patients whose predominant POST symptom is throat
pain may have altered perception after analgesic
administration. We did not also measure plasma
concentration of the test agents to ascertain the
likelihood of systemic contribution to the outcome.
CONCLUSION
Pre-induction administration of nebulized Magnesium
or Ketamine can attenuate POST within the first 24
hours after endotracheal anaesthesia. Proper
nebulization technique and careful airway manipulation
are required to achieve this outcome.
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